Emparol-L Tablet 25 mg+5 mg is a combination oral anti-diabetic medication containing Empagliflozin (25 mg) and Linagliptin (5 mg). This dual-action formulation is designed for the management of type 2 diabetes mellitus (T2DM) in adults, offering enhanced blood sugar control through complementary mechanisms.

• Empagliflozin is a SGLT2 (sodium-glucose co-transporter 2) inhibitor that reduces glucose reabsorption in the kidneys, promoting excretion of excess glucose via urine, which helps lower blood sugar levels, reduce body weight, and improve cardiovascular outcomes.

• Linagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that enhances incretin hormones, stimulating insulin release and reducing glucagon production in response to meals. This action helps control postprandial and fasting blood glucose levels.

The combination of Empagliflozin and Linagliptin in Emparol-L provides comprehensive glycemic control by targeting both renal glucose excretion and pancreatic insulin regulation, making it an effective option for patients inadequately controlled on diet, exercise, or monotherapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Emparol-L Tablet 25 mg+5 mg is indicated for:

• Type 2 Diabetes Mellitus (T2DM): For adults who require better glycemic control when diet, exercise, or single-agent therapy is insufficient

• Adjunct therapy: Can be used alongside other anti-diabetic medications, including metformin, under medical supervision

• Postprandial and fasting glucose control: Manages both meal-related and basal hyperglycemia

• Cardiovascular risk reduction: Empagliflozin component may lower the risk of heart failure hospitalization and cardiovascular death in adults with T2DM and established cardiovascular disease

• Weight management: Promotes modest weight reduction through urinary glucose excretion

Dosage and Administration

• Adults: One tablet once daily, preferably in the morning, with or without food, or as prescribed by a healthcare provider

• Swallow the tablet whole with water; do not crush, split, or chew

• Monitor blood glucose, HbA1c, kidney function, and overall metabolic health regularly during therapy

• Maintain dietary management and exercise alongside medication for optimal results

• Dose adjustment may be required in patients with renal impairment or other medical conditions

Precautions

• Not recommended for patients with type 1 diabetes, severe kidney impairment, or end-stage renal disease

• Use caution in individuals with a history of urinary tract infections, genital infections, or dehydration

• Avoid use in patients with severe liver disease unless prescribed by a physician

• Monitor for signs of hypoglycemia when used with insulin or sulfonylureas

• Patients should inform their healthcare provider about all medications to prevent drug interactions, including diuretics or other anti-diabetic drugs

• Pregnant or breastfeeding women should consult their physician before use

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Emparol-L Tablet 25 mg+5 mg is generally well tolerated. Common side effects may include:

• Increased urination and thirst

• Urinary tract infections

• Genital yeast infections

• Nasopharyngitis or mild respiratory infections

• Headache or dizziness

Rare but serious side effects may include:

• Ketoacidosis (high blood ketones)

• Severe dehydration or hypotension

• Hypoglycemia when combined with insulin or sulfonylureas

• Kidney impairment or electrolyte imbalance

• Severe allergic reactions, including rash, swelling, or difficulty breathing

Patients experiencing severe or persistent side effects should seek medical attention immediately.

Storage

Store in a cool, dry place below 30°C, protected from sunlight and moisture. Keep out of reach of children.

Emparol-L Tablet 25 mg+5 mg offers dual-action blood sugar control through the combined benefits of Empagliflozin and Linagliptin, providing improved glycemic management, cardiovascular protection, and weight support. Its convenient once-daily oral dosing makes it an effective and reliable choice for adults managing type 2 diabetes.